494 related articles for article (PubMed ID: 8735431)
1. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R
J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
[TBL] [Abstract][Full Text] [Related]
2. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
6. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
7. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
8. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users].
Wang YC; Xu SH; Li XH; Song AJ; Jia XR; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963
[TBL] [Abstract][Full Text] [Related]
9. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
[TBL] [Abstract][Full Text] [Related]
10. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
12. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
[TBL] [Abstract][Full Text] [Related]
13. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B virus markers among intravenous drug abusers in Stockholm: impact of heterosexual transmission.
Struve J; Käll K; Stendahl P; Scalia-Tomba G; Giesecke J; Weiland O
Scand J Infect Dis; 1993; 25(1):8-13. PubMed ID: 8460353
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
Fuglsang T; Fouchard JR; Ege PP
Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.
Tripathi AK; Khanna M; Gupta N; Chandra M
J Assoc Physicians India; 2007 Jun; 55():429-31. PubMed ID: 17879496
[TBL] [Abstract][Full Text] [Related]
18. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
Jindal N; Arora U; Singh K
Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiologic studies on HCV and HBV infections among intravenous drug users in the area with high HIV infection].
Cheng H
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):275-8. PubMed ID: 8137408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
